Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Blood
|
February 21, 2008
Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study
Drew J Winston, Jo-Anne H Young, Vinod Pullarkat, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 4, 2024
AURORA: A New Dawn
Genovefa A Papanicolaou, Robin K Avery, Catherine Cordonnier, et al.
Open Forum Infectious Diseases
|
July 16, 2020
Immunogenicity of Inactivated Varicella Zoster Vaccine in Autologous Hematopoietic Stem Cell Transplant Recipients and Patients With Solid or Hematologic Cancer
Michael J Boeckh, Ann M Arvin, Kathleen M Mullane, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 8, 2018
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation
Francisco M Marty, Drew J Winston, Roy F Chemaly, et al.
The Journal of Infectious Diseases
|
August 3, 2013
Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults
Kathleen M Mullane, Drew J Winston, Michael S Wertheim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 13, 2018
A Randomized, Placebo-controlled Trial of Fidaxomicin for Prophylaxis of Clostridium difficile-associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
Kathleen M Mullane, Drew J Winston, Ajay Nooka, et al.
The Lancet. Infectious Diseases
|
March 19, 2011
Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial
Francisco M Marty, Per Ljungman, Genovefa A Papanicolaou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 21, 2020
Cytomegalovirus (CMV) Cell-Mediated Immunity and CMV Infection After Allogeneic Hematopoietic Cell Transplantation: The REACT Study
Roy F Chemaly, Lynn El Haddad, Drew J Winston, et al.
The New England Journal of Medicine
|
January 25, 2002
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever
Thomas J Walsh, Peter Pappas, Drew J Winston, et al.
Open Forum Infectious Diseases
|
August 28, 2023
Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant
Ella J Ariza-Heredia, Drew J Winston, Scott D Rowley, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Blood
|
February 21, 2008
Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study
Drew J Winston, Jo-Anne H Young, Vinod Pullarkat, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 4, 2024
AURORA: A New Dawn
Genovefa A Papanicolaou, Robin K Avery, Catherine Cordonnier, et al.
Open Forum Infectious Diseases
|
July 16, 2020
Immunogenicity of Inactivated Varicella Zoster Vaccine in Autologous Hematopoietic Stem Cell Transplant Recipients and Patients With Solid or Hematologic Cancer
Michael J Boeckh, Ann M Arvin, Kathleen M Mullane, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 8, 2018
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation
Francisco M Marty, Drew J Winston, Roy F Chemaly, et al.
The Journal of Infectious Diseases
|
August 3, 2013
Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults
Kathleen M Mullane, Drew J Winston, Michael S Wertheim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 13, 2018
A Randomized, Placebo-controlled Trial of Fidaxomicin for Prophylaxis of Clostridium difficile-associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
Kathleen M Mullane, Drew J Winston, Ajay Nooka, et al.
The Lancet. Infectious Diseases
|
March 19, 2011
Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial
Francisco M Marty, Per Ljungman, Genovefa A Papanicolaou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 21, 2020
Cytomegalovirus (CMV) Cell-Mediated Immunity and CMV Infection After Allogeneic Hematopoietic Cell Transplantation: The REACT Study
Roy F Chemaly, Lynn El Haddad, Drew J Winston, et al.
The New England Journal of Medicine
|
January 25, 2002
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever
Thomas J Walsh, Peter Pappas, Drew J Winston, et al.
Open Forum Infectious Diseases
|
August 28, 2023
Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant
Ella J Ariza-Heredia, Drew J Winston, Scott D Rowley, et al.
Page
of 5